A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma
CONCLUSION: The ARG-based signature may provide a promising direction for prognosis prediction and treatment optimization for DLBCL patients.PMID:38709202 | DOI:10.1080/14737159.2024.2351465
Source: Expert Review of Molecular Diagnostics - Category: Laboratory Medicine Authors: Mingze Guan Hua Zhao Qi Zhang Li Li Xiaobo Wang Bo Tang Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Environmental Health | Genetics | Laboratory Medicine | Lymphoma | Revlimid | Study | Training | Universities & Medical Training